Background: An association between chronic hyperaldosteronism and medullary nephrocalcinosis has rarely been made, with only a handful of cases described in literature.

Case Report: We describe five cases of hyperaldosteronism with a long- standing history in whom associated medullary nephrocalcinosis was established.

Conclusions: We infer that a chronic hyperaldosteronic status, whether primary or secondary, is a causal factor in the etiopathogenesis of medullary nephrocalcinosis. This article illustrates and summarizes various postulated theories that support our proposed association between hyperaldosteronism and nephrocalcinosis. We conclude that chronic hyperaldosteronism should be included as one of the causes of nephrocalcinosis and that our case series emphasizes the need of a well-organized retrospective study to prove it further.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564071PMC
http://dx.doi.org/10.12659/PJR.894674DOI Listing

Publication Analysis

Top Keywords

medullary nephrocalcinosis
16
chronic hyperaldosteronism
12
association chronic
8
hyperaldosteronism medullary
8
nephrocalcinosis
6
hyperaldosteronism
5
medullary
4
nephrocalcinosis background
4
background association
4
nephrocalcinosis rarely
4

Similar Publications

Background: Dent's disease (DD) is a rare X-linked recessive tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis/nephrolithiasis and chronic kidney disease. With this manuscript, we reported three patients diagnosed as DD in our department in the last 10 years and thereby described the genetics, pathophysiology, clinical presentation, course and management of the disease.

Cases: The first case was a male newborn who was consulted to our department after medullary nephrocalcinosis was detected.

View Article and Find Full Text PDF

A case of enamel renal syndrome from a novel genetic mutation, multidisciplinary management and long-term prognosis.

Ups J Med Sci

October 2024

Institute of Surgical Sciences, Department of Plastic and Oral & Maxillofacial Surgery, Uppsala University, Uppsala, Sweden.

Article Synopsis
  • Enamel renal syndrome (ERS) presents unique challenges in diagnosis and treatment, primarily involving issues with enamel formation and kidney health, making patient management complex and often requiring specialized dental care.
  • A case study demonstrates the long-term management of a patient diagnosed with ERS after a delay in diagnosis, including genetic confirmation and ongoing nephrological monitoring for related complications.
  • The findings emphasize the necessity for integrated dental and medical care for patients with syndromic disorders, as well as the need for continuous monitoring of renal health, which shows a favorable prognosis despite the intricate nature of the condition.
View Article and Find Full Text PDF

Introduction: Christianson syndrome is a rare neurodevelopmental disorder associated with mutations in the gene located on the chromosome X. It is characterized by intellectual disability, developmental delay, speech and language impairments, dysmorphic features, seizures, ataxia, and neurobehavioral problems.

Case Presentation: A 5-year-old boy was presented with respiratory failure and then progressive muscle weakness in all four extremities.

View Article and Find Full Text PDF

Medullary nephrocalcinois and primary hyperaldosteronism - A rare and under recognised association.

J Postgrad Med

July 2024

Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu, India.

Medullary nephrocalcinosis is an uncommon manifestation of primary hyperaldosteronism (PHA) and the exact etiology of this association is still debated. Here we report three cases of PHA with medullary nephrocalcinosis and how medullary nephrocalcinosis in one patient led to misdiagnosis as renal tubular acidosis (RTA). Although PHA and RTA can share overlapping symptoms, careful evaluation of clinical presentation, biochemical tests, and imaging studies are essential to differentiate between the two conditions and ensure appropriate management.

View Article and Find Full Text PDF

Introduction: Patients with primary hyperoxaluria type 1 (PH1), a genetic disorder associated with hepatic oxalate overproduction, frequently experience recurrent kidney stones and worsening kidney function. Lumasiran is indicated for the treatment of PH1 to lower urinary and plasma oxalate (POx).

Methods: ILLUMINATE-A (NCT03681184) is a phase III trial in patients aged ≥6 years with PH1 and estimated glomerular filtration rate (eGFR) ≥30 ml/min per 1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!